Work in progress

A solution developed by the Nano-Oncology and Translational Therapeutics Unit of the Health Research Institute of Santiago de Compostela.

Background

The way of understanding medicine has evolved dramatically in recent years. Currently, the objective is to provide suitable therapeutic alternatives for each patient, in a personalized way, attending to each particular condition and disease. The knowledge generated about the molecular characteristics of unhealthy cells and tissues, and the ability to generate drugs against very specific targets thanks to the revolution in molecular medicine and biotechnology, are making the great promise of precision medicine, giving the right treatment at the right time to the right person, to become a reality.

What does DIVERSA propose?

DIVERSA technologies aims to provide delivery solutions through the design of new and safe vehicles, easy to produce and versatile, which can be adapted to different types of therapeutic molecules (both biomolecules and drugs) to facilitate their release, especially when their target is found at the intracellular level and access is limited. DIVERSA is focused on promoting the transfer to the clinic of new therapeutic molecules with high potential and high added value, based on a patented technology.

DIVERSA therapeutics is focused on the development of new therapies to satisfy unresolved medical needs, such as providing new approaches for the treatment of metastasis. The study at molecular level of metastatic cells has led us to the identification of a new target with a fundamental role in the development and advance of the disease. DIVERSA therapeutics aims to explore different therapeutic strategies to change the course of metastasis. Additional developments will focus on other diseases with high social and emotional impact.

About us?

We are a multidisciplinary team made up of professionals with extensive experience in the field of scientific research and applied development.